Peter Zdziarski: Protecting Patient Data in the Rare Disease Community
Peter Zdziarski, Vice President and Marketing Director at Glanzmann’s Research Foundation, shared a post on LinkedIn։
”As a patient with a rare disease, my data is highly valuable.
If you are part of the Glanzmann Thrombasthenia community or the rare disease community at large, yours is too!
Before taking part in one of the many surveys out there, a few things to keep in mind:
- What will happen to your data, how it will be shared, and for how long it will be retained.
This establishes where your data goes and how long it lives outside of your control.
In rare disease communities, even anonymous data can be sensitive and have a long shelf life.
- If ‘strong legal or liability language’ seems out of proportion to a ‘simple survey.’
Legalistic language, disclaimers, or liability notices may indicate a higher risk or more extensive data use than the survey itself suggests.
This should trigger a closer look.
- Who the research partner is and what they gain from the data.
Knowing whether the partner is academic, non-profit, or pharmaceutical can help understand the intent and whether the main advantage is patient-centered, commercial, or a combination of both.
That being said, surveys are important.
When conducted in a transparent and respectful manner, they can increase awareness, inform better research, and give a voice to patients with rare diseases who are often unheard.”
Stay updated with Hemostasis Today.
-
Mar 8, 2026, 11:55Abishek Saravanan: Neuroprotective Benefits of Sovateltide in Real-World Stroke Management
-
Mar 8, 2026, 11:39Shwetha Shenod: The Importance of Early Recognition to Reduce Stroke Risk in Lyme-Associated Vasculitis
-
Mar 8, 2026, 11:21João Duarte: Navigating Tandem Occlusions in Acute Ischemic Stroke
-
Mar 8, 2026, 10:57Christoph B. Olivier: Celebrating the Transformative Impact of Women in Research
-
Mar 8, 2026, 10:47Jonathan Douxfils: In Contraception for Healthy Women, Safety Must Remain the Leading Criterion
-
Mar 8, 2026, 10:35Mavis Agnes Kisakye: Celebrating the Mothers of the Haemophilia Community
-
Mar 8, 2026, 07:52Maxime Dely: Blood Plasma Remains the Only Possible Source of Human Albumin
-
Mar 8, 2026, 07:28Arun V J: Is Plasma The Semiconductor Chips In Healthcare?
-
Mar 8, 2026, 07:26Roberta Gualtierotti: Can Artificial Intelligence Help Detect Early Joint Bleeding in Hemophilia?